In vivoInduction of Resistance to Gemcitabine Results in Increased Expression of Ribonucleotide Reductase Subunit M1 as the Major Determinant-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In vivoInduction of Resistance to Gemcitabine Results in Increased Expression of Ribonucleotide Reductase Subunit M1 as the Major Determinant

Published:2005-10-15 Issue:20 Volume:65 Page:9510-9516
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Bergman Andries M.,Eijk Paul P.,Ruiz van Haperen Veronique W.T.,Smid Kees,Veerman Gijsbert,Hubeek Isabelle,van den IJssel Paul,Ylstra Bauke,Peters Godefridus J.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabidiol exhibits potent anti-cancer activity against gemcitabine-resistant cholangiocarcinoma via ER-stress induction in vitro and in vivo;BMC Complementary Medicine and Therapies;2024-08-30

2. MiCK: a database of gut microbial genes linked with chemoresistance in cancer patients;2024-07-24

3. Potential application of nanotechnology in the treatment and overcoming of pancreatic cancer resistance;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024

4. Dynamic Behavior and Ligand Binding Properties of the Wild Type Deoxycytidine Kinase and its Characterized Gemcitabine-Resistant Variant: A Bioinformatics and Computational Study;Journal of Computational Biophysics and Chemistry;2023-08-24

5. Aberrant transcription factors in the cancers of the pancreas;Seminars in Cancer Biology;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP